Inhaled iloprost in lung transplantation: can it avoid extracorporeal circulation in patients with severe pulmonary hypertension?
Winterhalter
Michael
M
Department of Anaesthesiology, Hannover Medical School, Hannover, Germany. Winterhalter.Michael@mh-hannover.de <Winterhalter.Michael@mh-hannover.de>
Simon
Andre
A
Fischer
Stefan
S
Gras
Clemens
C
Zuk
Janusz
J
Piepenbrock
Siegfried
S
Strüber
Martin
M
D000280:Administration, Inhalation; D000328:Adult; D000075202:Contraindications; D005112:Extracorporeal Circulation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016285:Iloprost / Q000008:administration & dosage*; D007432:Intraoperative Period; D016040:Lung Transplantation / Q000379:methods*; D011656:Pulmonary Emphysema / Q000150:complications / Q000601:surgery*; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage*
D014665:Vasodilator Agents; D016285:Iloprost